{{DISPLAYTITLE:βk-2C-B}}
{{Drugbox
| IUPAC_name        = 2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one
| image             = Βk-2C-B-skeletal.svg
| width             =
| alt               =
| image2            =
| width2            =
| alt2              =

<!-- Clinical data -->
| legal_AU =
| legal_CA = Schedule III
| legal_UK =
| legal_US =
| legal_status      = Illegal in Sweden and Switzerland
| dependency_liability =
| routes_of_administration = Oral

<!-- Pharmacokinetic data -->
| bioavailability   =
| protein_bound     =
| metabolism        =
| elimination_half-life =
| excretion         =

<!-- Identifiers -->
| CAS_number        = 807631-09-0
| CAS_supplemental  =
| ATCvet            =
| PubChem           = 11288812
| PubChemSubstance  =
| IUPHAR_ligand     =
| DrugBank          =
| ChemSpiderID      = 9463799
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = W6KJ195I24
| KEGG              =
| ChEBI             =
| ChEMBL            =
| synonyms          =

<!-- Chemical data -->
| chemical_formula  = |C=10 | H=12 | N=1 | O=3 | Br=1
| molecular_weight  = 274.111 g/mol (freebase)<br>310.572 g/mol ([[hydrochloride|HCl]] salt)
| smiles            = COC1=CC(C(=O)CN)=C(OC)C=C1Br
| StdInChI          = InChI=1S/C10H12BrNO3/c1-14-9-4-7(11)10(15-2)3-6(9)8(13)5-12/h3-4H,5,12H2,1-2H3
| StdInChI_comment  =
| StdInChIKey       = HFYJGAIOBIDRPX-UHFFFAOYSA-N
| density           =
| melting_point     =
| melting_high      =
| melting_notes     =
| boiling_point     =
| boiling_notes     =
| solubility        =
| specific_rotation =
| sec_combustion    =
}}

'''βk-2C-B''' ('''beta-keto 2C-B''', '''bk-2C-B''') is a [[psychedelic drug]] which is structurally related to [[2C-B]] and [[BOB (psychedelic)|BOB]]<ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/jm040082s | title=β-Oxygenated Analogues of the 5-HT<sub>2A</sub> Serotonin Receptor Agonist 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane |author1=Richard A. Glennon |author2=Mikhail L. Bondarev |author3=Nantaka Khorana |author4=Richard Young |author5=Jesse A. May |author6=Mark R. Hellberg |author7=Marsha A. McLaughlin |author8=Najam A. Sharif | journal=Journal of Medicinal Chemistry | date=November 2004 | volume=47 | issue=24 | pages=6034–6041 | doi=10.1021/jm040082s | pmid=15537358}}</ref> and has been sold online as a [[designer drug]].<ref>{{cite journal | url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1699/abstract | title=Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B) |author1=John D. Power |author2=Pierce Kavanagh |author3=John O'Brien |author4=Michael Barry |author5=Brendan Twamley |author6=Brian Talbot |author7=Geraldine Dowling |author8=Simon D. Brandt | journal=Drug Testing and Analysis | date=June 2015 | volume=7 | issue=6 | pages=512–518 | doi=10.1002/dta.1699 | pmid=25078895}}</ref><ref>{{cite journal | url=http://onlinelibrary.wiley.com/doi/10.1002/rcm.7211/abstract | title=Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance |author1=Giampietro Frison |author2=Sara Odoardi |author3=Samuela Frasson |author4=Rocco Sciarrone |author5=Giorgio Ortar |author6=Francesco Saverio Romolo |author7=Sabina Strano Rossi | journal=Rapid Communications in Mass Spectrometry | date=July  2015 | volume=29 | issue=13 | pages=1196–1204 | doi=10.1002/rcm.7211 | pmid=26395784}}</ref>

===Analogues and derivatives===
{{2C-B analogues and derivatives}}

==Legal status==

===Canada===
As of 12 October 2016, βk-2C-B became a controlled substance (Schedule III) in Canada.<ref>{{cite web | url = http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php | title = Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines) | work = Controlled Substances Act}}</ref>

===Europe===

βk-2C-B is illegal in Switzerland,<ref>{{cite web | url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html | title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien | publisher=Der Bundesrat | language=German}}</ref> Sweden<ref>{{cite web |url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/augusti/nya-substanser-klassas-som-narkotika-eller-halsofarlig-vara/ | title=Nya substanser klassas som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | date=18 August 2015 | language=Swedish}}</ref> and the United Kingdom<ref>{{cite web|title=Psychoactive Substances Act 2016|url=http://www.legislation.gov.uk/ukpga/2016/2|publisher=Home Office|accessdate=8 September 2016|ref=7}}</ref>

==See also==
* [[2C (psychedelics)|2C-x]]
* [[BOHD (psychedelic)]]
* [[Substituted cathinone]]
* [[Substituted phenethylamine]]s

==References==
{{Reflist}}
{{Serotonergics}}
{{Phenethylamines}}
{{Psychedelics}}

{{DEFAULTSORT:Betak-2C-B}}
[[Category:Bromoarenes]]
[[Category:Designer drugs]]
[[Category:Psychedelic phenethylamines]]
[[Category:Serotonin receptor agonists]]


{{hallucinogen-stub}}